Lataa...
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
The success of chimeric antigen receptor-modified T-cell (CAR-T) therapy for B-cell lymphocyte malignancies targeting CD19 places it in a rapidly growing field in cancer immunotherapy for both hematological and solid tumors. However, the two types of tumor are quite different in the following respec...
Tallennettuna:
| Julkaisussa: | Onco Targets Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309774/ https://ncbi.nlm.nih.gov/pubmed/30636882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S190336 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|